VICTOZA 3-PAK 18 MG/3 ML PEN

liraglutide
$87.8352per ML
High Outlier

Strength

6 mg/mL

Manufacturer

Novo Nordisk

NDC

00169406013

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

LIRAGLUTIDE

Approval Type

New Drug (NDA)

FDA Application

NDA022341

On Market Since

1/25/2010

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price History

1W

0.0%

1M

-0.0%

3M

+0.1%

6M

+0.3%

1Y

+0.4%

3Y

-26.2%

5Y

-18.9%

All

+65.2%